Industry Overview

C-Arms market was valued at $1.9 billion in 2025 and is projected to reach $3.3 billion by 2035, expanding at a CAGR of 5.5% during the forecast period from 2026 to 2035. The market is witnessing significant growth due to the increasing volume of minimally invasive surgeries, rising prevalence of orthopedic and cardiovascular disorders, and growing demand for real-time intraoperative imaging systems.

C-arms are fluoroscopy-based imaging systems extensively used in orthopedic surgeries, trauma procedures, cardiovascular interventions, pain management, and gastrointestinal surgeries. According to the World Health Organization (WHO), musculoskeletal conditions impact approximately 1.71 billion people globally, making orthopedic imaging one of the largest application areas for C-arm systems. Furthermore, the WHO estimates that cardiovascular diseases cause nearly 17.9 million deaths annually worldwide, significantly increasing demand for image-guided interventions and fluoroscopic procedures.

The increasing shift toward minimally invasive surgery is further accelerating the adoption of mobile C-arms and flat panel detector (FPD)-based systems. Hospitals and ambulatory surgical centers are increasingly investing in compact and advanced imaging technologies to improve surgical precision, reduce recovery time, and enhance patient outcomes. Technological advancements such as AI-enabled imaging, robotic mobility, and low-dose radiation systems are further strengthening market growth.

Market Dynamics

Driver: Rising Demand for Minimally Invasive and Image-Guided Surgeries

The increasing adoption of minimally invasive surgeries (MIS) across orthopedic, cardiovascular, and pain management applications is a major growth driver for the C-arms market. According to the OECD, the number of orthopedic and joint replacement procedures continues to increase globally due to aging populations and the rising incidence of obesity-related musculoskeletal disorders. The WHO estimates that by 2030, one in six people globally will be aged 60 years or older, significantly increasing demand for surgical interventions requiring intraoperative imaging systems.

C-arms provide real-time fluoroscopic guidance during procedures, enabling surgeons to improve precision and reduce procedural complications. Hospitals and ASCs are increasingly preferring mobile C-arms because of their portability and lower infrastructure costs. In 2025 and 2026, major manufacturers focused on introducing AI-assisted imaging technologies and advanced digital detectors to improve workflow efficiency and image quality. Siemens Healthineers introduced autonomous mobile imaging systems, while GE HealthCare expanded advanced 3D imaging capabilities in surgical fluoroscopy platforms to strengthen its interventional imaging portfolio.

Challenge: High Equipment Cost and Radiation Safety Concerns

Despite growing adoption, high acquisition and maintenance costs remain a major challenge for the C-arms market, particularly in emerging economies. Advanced FPD-based systems and hybrid operating room imaging platforms require substantial capital investment, limiting adoption among small healthcare facilities and specialty clinics. Hospitals additionally face recurring expenses associated with maintenance, software upgrades, and radiation compliance standards.

Radiation exposure risks for healthcare professionals and patients also remain a key concern. Regulatory agencies such as the U.S. FDA continue to emphasize radiation dose optimization and operator safety measures in fluoroscopic imaging systems. Manufacturers are increasingly investing in low-dose imaging technologies, AI-assisted image enhancement, and advanced detector systems to address these concerns. Supply chain disruptions affecting semiconductor components and detector manufacturing have also impacted equipment production timelines and pricing during recent years.

Market Segmentation

• Based on the product type, the market is segmented into fixed C-arms and mobile C-arms.
• Based on the technology, the market is segmented into image intensifier-based C-arms and flat panel detector (FPD)-based C-arms.
• Based on the end user, the market is segmented into hospitals, ambulatory surgical centers (ASCS), and specialty clinics.

Mobile C-Arms Segment Leads the Market

The Mobile C-Arms segment accounted for the largest share of the global market in 2025, owing to its broad adoption across orthopedic surgery, trauma imaging, cardiovascular procedures, and ambulatory care settings. Mobile systems offer greater flexibility, portability, and operational efficiency compared to fixed imaging systems. Increasing preference for outpatient surgical procedures and growing establishment of ASCs globally are significantly supporting segment growth.

Between 2022 and 2026, major companies launched advanced mobile imaging platforms integrated with digital flat-panel detector technologies and AI-enabled imaging solutions. Siemens Healthineers expanded its mobile fluoroscopy portfolio with robotic-assisted imaging systems, while GE HealthCare focused on advanced visualization solutions for interventional procedures. Mobile C-arms are also witnessing strong adoption in emergency trauma care and pain management applications due to their ease of deployment and lower infrastructure requirements.

Flat Panel Detector (FPD)-Based C-Arms Segment to Record Strong Growth

The Flat Panel Detector (FPD)-Based C-Arms segment is expected to register the fastest growth during the forecast period due to increasing demand for superior image quality, lower radiation exposure, and enhanced digital imaging capabilities. FPD technology offers improved visualization accuracy, better workflow integration, and faster image acquisition compared with traditional image intensifier systems.

Growing adoption of advanced minimally invasive procedures and increasing investments in hybrid operating rooms are accelerating segment expansion. Healthcare providers are increasingly upgrading legacy imaging systems with FPD-enabled solutions to improve clinical efficiency and patient safety. Manufacturers are investing heavily in AI-powered imaging software, 3D visualization, and robotic-assisted mobility systems to strengthen product differentiation and technological competitiveness.

Regional Outlook

The global C-Arms market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).

United States Leads the Market

The United States accounted for the largest share of the global C-Arms market due to strong healthcare infrastructure, high adoption of minimally invasive surgeries, and increasing investment in advanced imaging technologies. According to the Centers for Disease Control and Prevention (CDC), approximately 6.2 million orthopedic procedures are performed annually in the U.S., significantly driving demand for intraoperative imaging systems. Additionally, the American Hospital Association reports continued expansion of ambulatory surgical centers across the country, further supporting mobile C-arm adoption.

The presence of leading imaging manufacturers such as GE HealthCare and Siemens Healthineers, combined with favourable reimbursement structures and rapid technological adoption, continues to strengthen market growth in the United States.

China to Record Strong Growth

China is projected to witness strong growth in the global C-Arms market due to increasing healthcare infrastructure investments, rising surgical volumes, and rapid expansion of medical imaging capabilities. According to the National Bureau of Statistics of China, healthcare expenditure in China continues to rise steadily, with increasing investments in hospital modernization and digital healthcare technologies.

The growing aging population and increasing incidence of chronic diseases are accelerating demand for minimally invasive procedures and advanced fluoroscopic imaging systems. Domestic and international manufacturers are expanding manufacturing and distribution operations across China to capitalize on the rising demand for cost-effective mobile imaging solutions. Government initiatives promoting healthcare modernization and medical device innovation are also supporting long-term market growth.

Competitive Landscape

The global C-arms market is moderately consolidated, with major players competing based on technological innovation, imaging quality, product portability, and radiation reduction capabilities. Companies are increasingly focusing on AI-enabled imaging systems, robotic-assisted mobility, and advanced digital fluoroscopy technologies to strengthen their market positions.

Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, and Shimadzu Corporation collectively account for a significant share of the global market. These companies maintain strong global distribution networks and continuously invest in R&D activities to introduce advanced mobile imaging systems. Manufacturers are also focusing on strategic collaborations with hospitals and surgical centers to improve the adoption of next-generation fluoroscopic imaging platforms.

Recent Developments

• In November 2025, Shimadzu Medical Systems USA announced the launch of the SC15 mobile C-arm imaging system in the United States. The system features advanced flat panel detector (FPD) technology, a 15kW generator, auto-collimation functionality, and a 43-inch display to enhance intraoperative imaging and workflow efficiency across orthopedic, vascular, pain management, and general surgical procedures.

• In October 2025, Philips announced the 5,000th installation of its Zenition mobile C-arm imaging system at Kolín Regional Hospital in the Czech Republic. Since its launch in 2019, the Zenition platform has been adopted across more than 170 countries, supporting image-guided surgical and interventional procedures. The system incorporates workflow-enhancing technologies such as Position Memory and BodySmart software to improve imaging efficiency, reduce repositioning requirements, and support minimally invasive surgical care.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global C-arms market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.